DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Bamifylline
Bamifylline
Spheroids
The National Drugs List
Stems for Nonproprietary Drug Names
TR-473: Theophylline (CASRN 58-55-9) in F344/N Rats And
New Galenic Formulations with Programmed Release
SA1 Oxygen Binding Heme Proteins
Pharmaceutical Appendix to the Harmonized Tariff Schedule
Pharmaceutical Appendix to the Tariff Schedule 2
(19) 11 Patent Number: 6165500
L:\0901 with Peru\0901PHARMAPPX.Wpd
H|||||||||I|| USOOSO91 189A United States Patent (19) 11 Patent Number: 5,091,189 Heafield Et Al
Modulation of Neurogenesis by PDE Inhibition
Doxofylline Is Not Just Another Theophylline!
Wo 2008/127291 A2
European Patent Office
Review of Existing Classification Efforts
2021 Equine Prohibited Substances List
Wo 2007/120485 A2
Top View
X-Ray Microscope Röntgenstrahlmikroskop Microscope À Rayons X
Martindale 38 Brochure
This Item Is the Archived Peer-Reviewed Author-Version Of
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2016) Annotated for Statistical Reporting Purposes
Development and Validation of Rp-Hplc Method for the Determination of Bamifylline Hydrochloride in Tablet Dosage Form
Amended Clinical Trial Protocol 02
2019 Equine Prohibited Substances List
Development and Validation of UV Spectrophotometric Method for the Determination of Bamifylline Hydrochloride in Pharmaceutical
Copyrighted Material
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
Effects of A1 Adenosine Receptor Antagonism Against Ischaemia-Reperfusion Damage and Coronary Microcirculation in Isolated Working Rat Hearts
Novel Adenosine Receptor Antagonist.Pdf
Customs Tariff - Schedule Xxi - 1
Medicines and Cosmetics Regulations 1998
Caffeine Hydrate (BANM) Smaller Caffeine Loading Dose, Repeated Several Hours Later
Literature Search Strategy for Treatment of Stable
Harmonized Tariff Schedule of the United States (2006) Annotated for Statistical Reporting Purposes
Efficacy and Safety Profile of Xanthines in COPD: a Network Meta-Analysis
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmaceutical Appendix to the Tariff Schedule 2
Bakul Pharma Private Limited
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Efficacy and Safety of Doxofylline Compared to Theophylline in Chronic Reversible Asthma – a Double-Blind Randomized Placebo-C
(12) Patent Application Publication (10) Pub. No.: US 2009/0142797 A1 Zhang Et Al
The Hemodynamic Effects of Aminophylline, Adenosine, Losartan and Nitric Oxide Administered Shortly After Right Heart Infarct in a Porcine Model
(12) Patent Application Publication (10) Pub. No.: US 2006/0083714 A1 Warner (43) Pub
ICD-10-CM Table of Drugs 2019
(12) Patent Application Publication (10) Pub. No.: US 2004/0105819 A1 Hale Et Al
(12) United States Patent (10) Patent No.: US 6,869,974 B1 Del Soldato (45) Date of Patent: Mar
Substance Activity
WO 2015/015459 Al 5 February 2015 (05.02.2015) P O P C T
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances